SunRegen Healthcare AG is a pioneering biopharmaceutical company based in the Basel Area, Switzerland, focused on developing innovative, neuroprotective, and neurorescuing therapies for ophthalmic and neurodegenerative diseases. Our lead candidate, SBC003, is a synthetic small molecule in late-stage preclinical development for conditions such as retinitis pigmentosa, glaucoma-related optic atrophy, and dry age-related macular degeneration-areas with significant unmet medical needs and limited current treatments.
SBC003 is distinguished by its ability to cross the blood-brain and retinal barriers, oral bioavailability, and favorable safety profile. Preclinical studies have demonstrated both neuroprotective and neurorescuing effects, with evidence of structural and functional rescue in animal models and promising results in compassionate human use. SBC003 is also being evaluated for additional orphan neurological indications.
Our dynamic team brings together passionate experts with proven track records in drug development, clinical research, and commercialization at leading pharmaceutical companies. SunRegen’s Scientific Advisory Board includes renowned neuroscientists and ophthalmology drug development leaders, and we collaborate with top academic and clinical institutions worldwide. Our achievements have been recognized with multiple industry awards and competitive grants, including support from the European Commission and Swiss government innovation agencies.
As we advance toward clinical trials, SunRegen is dedicated to building strategic partnerships and engaging with investors who share our vision of transforming neurodegenerative disease treatment. Join us as we work to rescue and restore vision for patients in need.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Basel, Ch
- Phone
- +41 (0)76 480 56 28
- in****@****egen.ch
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- sunregen.ch
- Keywords
- Biotech, Neurodegenerative disease, Optic Atrophy, Ophthalmology, Glaucoma, Optic Atrophy Eye Diseases.
- HQ
- Basel
Sunregen Healthcare Ag Questions
Sunregen Healthcare Ag's helpline number is +41 (0)76 480 56 28
Sunregen Healthcare Ag's website is sunregen.ch
Sunregen Healthcare Ag's LinkedIn profile is https://ch.linkedin.com/company/sunregen
Sunregen Healthcare Ag has
3 employees.
View email and phone details for 3
employees at Sunregen Healthcare Ag.
Sunregen Healthcare Ag's industry is
Biotechnology Research
Sunregen Healthcare Ag's top competitors are
E-Sense Innovation & Technology,
Yoni Solutions,
Ailsi,
Lactrims,
Prexton Therapeutics Sa,
Nerum Pharmaceuticals,
Renaldee,
Saverna Therapeutics Ag,
European Charcot Foundation,
Allocyte Pharmaceuticals Ag.
Sunregen Healthcare Ag's support email address is info@sunregen.ch
Sunregen Healthcare Ag's categories are Biotechnology Research
Sunregen Healthcare Ag's founding year is 2017
